H.C. Wainwright Maintains Adicet Bio(ACET.US) With Hold Rating
H.C. Wainwright Remains a Hold on Adicet Bio (ACET)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Celldex (CLDX), Oruka Therapeutics (ORKA) and Adicet Bio (ACET)
Adicet Bio Analyst Ratings
H.C. Wainwright Maintains Adicet Bio(ACET.US) With Hold Rating
Adicet Bio Analyst Ratings
Guggenheim Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $7
JMP Securities Maintains Adicet Bio(ACET.US) With Hold Rating
H.C. Wainwright Maintains Adicet Bio(ACET.US) With Hold Rating
H.C. Wainwright Sticks to Its Hold Rating for Adicet Bio (ACET)
Adicet Bio Analyst Ratings
H.C. Wainwright Maintains Adicet Bio(ACET.US) With Hold Rating
H.C. Wainwright Reaffirms Their Hold Rating on Adicet Bio (ACET)
Adicet Bio Analyst Ratings
H.C. Wainwright Maintains Adicet Bio(ACET.US) With Hold Rating
Guggenheim Initiates Adicet Bio(ACET.US) With Buy Rating, Announces Target Price $7
Adicet Bio Assumed at Buy From Neutral at Guggenheim
Truist Financial Maintains Adicet Bio(ACET.US) With Buy Rating
JonesTrading Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $4
Truist Financial Maintains Adicet Bio(ACET.US) With Buy Rating